Beta Bionics, Inc. (BBNX) News
Track canonical SquawkNews coverage tagged to BBNX, Beta Bionics, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 5 indexed stories across 4 publication days and is ordered by the same first-publication timeline used by LiveCast.
M
Beta Bionics wins FDA clearance for Mint pump
Beta Bionics said the FDA cleared its Mint pump, which does not require recharging and integrates with continuous glucose monitors. The company also lowered full-year 2026 sales guidance to $121 million-$126 million from
EQUITY | Sep 14, 2026, 11:36 AM UTC
L
William Blair initiates BBNX at Market Perform
William Blair initiates BBNX with a Market Perform rating; no price target or catalyst was supplied in the alert.
EQUITY | Aug 21, 2026, 11:58 AM UTC
H
BBNX: Stifel Maintains Buy
Stifel maintains buy rating on BBNX
EQUITY | Jul 30, 2026, 11:36 AM UTC
L
Beta Bionics Affirms FY2026 Sales Guidance of $131.000M-$136.000M vs $133.305M Est
Beta Bionics (NASDAQ: BBNX ) affirms FY2026 sales outlook from $131.000 million-$136.000 million to $131.000 million-$136.000 million vs $133.305 million estimate.
EARNINGS | Jul 29, 2026, 08:03 PM UTC
L
BBNX - Beta Bionics Announces Second Quarter 2026 Financial Results and Updates Full Year 2026 Guidance
BBNX - Beta Bionics Announces Second Quarter 2026 Financial Results and Updates Full Year 2026 Guidance
EARNINGS | Jul 29, 2026, 08:02 PM UTC